JESSICA MCCUE: Open Payments
NPI 1194294769 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,431 in 115 payments from 33 companies in 2025. Trend: 2023 $2,109 · 2024 $1,951 · 2025 $2,431
Food & beverage: $2,431
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $323 |
| ABBVIE INC. | 20 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $129 |
| SK Life Science, Inc. | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Amgen Inc. | 4 | $93 |
| Biogen, Inc. | 4 | $81 |
| GENZYME CORPORATION | 2 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
| Lilly USA, LLC | 4 | $72 |
Products named: QULIPTA, Fintepla, HYQVIA, KESIMPTA, BOTOX, Rystiggo, UPLIZNA, ACTHAR.
Industry payments across NC — which companies pay providers there.
